American Association for the Advancement of Science, Science Translational Medicine, 500(11), 2019
DOI: 10.1126/scitranslmed.aav5467
Full text: Unavailable
A variant erythroferrone contributes to hepcidin modulation and systemic iron accumulation in patients with SF3B1 -mutated myelodysplastic syndrome.